2 results
Approved WMORecruiting
Primary Objective: Our objective is to validate the safety, measured by radiological disease activity, of personalized extended interval dosing of natalizumab to >=6 weeks (with an aim natalizumab trough concentration of 5 µg/ml) in a large…
Approved WMORecruiting
To investigate the feasibility of a definitive RCT to assess the efficacy and safety of verapamil and quinidine in patients with short-coupled IVF.